ArticleAlimentary pharmacology & therapeuticsPublished
Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium
12 of 39 authors shown in byline order.
Regional connection
Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania. Affiliation source
Publication record
- Type
- Article
- Venue
- Alimentary pharmacology & therapeutics
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Cholangitis, Sclerosing; Inflammatory Bowel Diseases; Vancomycin; Anti-Bacterial Agents; Treatment Outcome; Remission Induction; Administration, Oral; Severity of Illness Index; Retrospective Studies; Cohort Studies; Adolescent
- PubMed ID
- 38462727
- Added to directory
- Source checked